M. Bobos

发表

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study.

G. Aravantinos, G. Fountzilas, P. Kosmidis, 2015, Histology and histopathology.

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab

G. Fountzilas, G. Pentheroudakis, A. Batistatou, 2012, Journal of Translational Medicine.

Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases.

Ioannis Pitas, Antonina Starita, Zenonas Theodosiou, 2008, Breast.

Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation

George Fountzilas, Christos Christodoulou, T. Economopoulos, 2008, Cancer investigation.

Potential value of PTEN in predicting cetuximab response in colorectal cancer: An exploratory study

G. Fountzilas, P. Kosmidis, D. Skarlos, 2008, BMC Cancer.

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study

G. Lazaridis, A. Psyrri, K. Papadopoulou, 2018, PloS one.

PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients

G. Aravantinos, H. Kalofonos, G. Fountzilas, 2015, Cancer Chemotherapy and Pharmacology.

Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer.

A. Psyrri, G. Fountzilas, K. Markou, 2014, Oral oncology.

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.

T. Ciuleanu, G. Fountzilas, K. Markou, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.

G. Fountzilas, G. Pentheroudakis, C. Papandreou, 2011, Anticancer research.

Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring.

A. Lallas, A. Kyrgidis, I. Boukovinas, 2020, Journal of the American Academy of Dermatology.

Aberrant CCND1 copies and cyclin D1 mRNA expression do not result in the production of functional cyclin D1 protein in anaplastic large cell lymphoma.

C. Papadimitriou, V. Kaloutsi, V. Kotoula, 2009, Histology and histopathology.

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

F. Fostira, D. Yannoukakos, H. Gogas, 2012, Breast Cancer Research and Treatment.

Histopathologic classification and prognostic factors of melanoma: a 2020 update.

M. Bobos, Mattheos Bobos, 2021, Italian journal of dermatology and venereology.

Immunohistochemical investigation of CD34 antigen in male breast carcinoma

D. Gerasimidou, M. Bobos, G. Karayannopoulou, 2007, Clinical and Experimental Medicine.

Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer

G. Lazaridis, G. Fountzilas, G. Pentheroudakis, 2014, Strahlentherapie und Onkologie.

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.

H. Gogas, K. Pavlakis, H. Kalofonos, 2010, Clinical breast cancer.

Genetic Variations of VEGFA Gene Are Associated With Infiltration of Adjacent Tissues and the Clinical Outcome of Patients With Nasopharyngeal Carcinoma

J. Constantinidis, D. Rontogianni, K. Papadopoulou, 2020, AntiCancer Research.

MMP 9 but Not EGFR , MET , ERCC 1 , P 16 , and P53 Is Associated with Response to Concomitant Radiotherapy , Cetuximab , and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

R. Wirtz, G. Aravantinos, G. Fountzilas, 2014 .

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

R. Wirtz, G. Aravantinos, G. Fountzilas, 2009, Journal of oncology.

Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.

M. Ignatiadis, P. Selviaridis, G. Fountzilas, 2006, Anticancer research.

Immunohistochemical Distinction Between Merkel Cell Carcinoma and Small Cell Carcinoma of the Lung

C. Papadimitriou, P. Hytiroglou, M. Bobos, 2006, The American Journal of dermatopathology.

A rare tumoral combination, synchronous lung adenocarcinoma and mantle cell lymphoma of the pleura

C. Foroulis, M. Bobos, G. Karayannopoulou, 2008, World journal of surgical oncology.

Molecular detection of Helicobacter pylori in a large Mediterranean river, by direct viable count fluorescent in situ hybridization (DVC-FISH).

E. Kazakos, I. Tirodimos, A. Haidich, 2014, Journal of water and health.

Detection of Helicobacter pylori in raw bovine milk by fluorescence in situ hybridization (FISH).

I. Tirodimos, M. Arvanitidou, M. Kalamaki, 2011, International journal of food microbiology.

Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers.

G. Lazaridis, D. Rontogianni, K. Papadopoulou, 2018, American journal of cancer research.

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.

N. Pavlidis, T. Ciuleanu, G. Fountzilas, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Protein expression patterns of cell cycle regulators in operable breast cancer

G. Lazaridis, C. Papadimitriou, G. Aravantinos, 2017, PloS one.

Double purse‐string suture surgical wound closure after excision of nipple adenoma of the breast: A case report

Theodosia Charitou, M. Bobos, K. Bimpa, 2022, Clinical case reports.

Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.

G. Fountzilas, K. Markou, A. Nikolaou, 2014, Anticancer research.

Predictive markers for the treatment of colorectal cancer with cetuximab.

G. Fountzilas, P. Kosmidis, P. Papakostas, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG)

K. Syrigos, G. Fountzilas, C. Papandreou, 2017, Journal of Neuro-Oncology.

Challenges in sarcoidosis and sarcoid‐like reactions associated to immune checkpoint inhibitors: A narrative review apropos of a case

A. Lallas, I. Boukovinas, Z. Apalla, 2020, Dermatologic therapy.

An Uncommon Case of Secondary Cardiac Lymphoma Manifested through Pre-Syncope , Syncope Episodes and Atrial Flutter

G. Kaiafa, A. Kalogera‐Fountzila, M. Bobos, 2017 .

RETRACTED: An Uncommon Case of Secondary Cardiac Lymphoma Manifested through Pre-Syncope, Syncope Episodes and Atrial Flutter

G. Kaiafa, A. Kalogera‐Fountzila, M. Bobos, 2016 .

Aberrant CCND 1 copies and cyclin D 1 mRNA expression do not result in the production of functional cyclin D 1 protein in anaplastic large cell lymphoma

C. Papadimitriou, V. Kaloutsi, V. Kotoula, 2022 .

In situ detection of hTERT variants in anaplastic large cell lymphoma

C. Papadimitriou, V. Kaloutsi, V. Kotoula, 2006, Leukemia & lymphoma.

Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches

S. Theocharis, D. Rontogianni, I. Theochari, 2021, Diagnostics.

Solitary fibrous tumor of the tongue: case report and literature review.

P. Hytiroglou, I. Dimitrakopoulos, M. Bobos, 2008, International journal of oral and maxillofacial surgery.

Endogenous Neurogenesis, Histological and Behavioral Monitoring of Recovery of Paraplegia, after Total Spinal Cord Transection in Mice

A. Anagnostopoulos, A. Fassas, M. Bobos, 2016 .

Crizotinib Failure in a TPM4-ALK-Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation.

F. Fostira, G. Fountzilas, P. Hytiroglou, 2017, JCO precision oncology.

Sialadenoma papilliferum of bronchus

C. Papadimitriou, P. Hytiroglou, M. Bobos, 2003, Virchows Archiv.

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study

A. Charchanti, H. Gogas, G. Aravantinos, 2022, Cancers.

Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary Dimitrios KrikelisGeorge PentheroudakisAnna GoussiaVassiliki Siozopoulou • Mattheos BobosDimitrios PetrakisAikaterini StoyianniVassilios Golfinopoulos • Andres CervantesTudor Ci

N. Pavlidis, T. Ciuleanu, G. Fountzilas, 2012 .

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

G. Fountzilas, N. Pavlidis, H. Gogas, 2012, Cancer Chemotherapy and Pharmacology.

Dermoscopy of papuloerythroderma of Ofuji

A. Lallas, Z. Apalla, M. Bobos, 2019, Photodermatology, photoimmunology & photomedicine.

Dermoscopy of Spitz/Reed naevi and management.

A. Lallas, A. Kyrgidis, Z. Apalla, 2019, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Clinicopathologically problematic melanocytic tumors: a case-based review

A. Lallas, G. Ferrara, D. Ioannides, 2018, Dermatology practical & conceptual.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

H. Gogas, G. Aravantinos, A. Psyrri, 2016, Journal of Translational Medicine.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

M. Dimopoulos, E. Giannoulatou, H. Gogas, 2016, Oncotarget.

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

K. Pavlakis, H. Kalofonos, G. Fountzilas, 2011, Breast Cancer Research and Treatment.

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer

A. Psyrri, G. Fountzilas, G. Pentheroudakis, 2019, ESMO Open.

Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

G. Fountzilas, A. Nikolaou, H. Linardou, 2011, Journal of oncology.

Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer

E. Giannoulatou, H. Gogas, G. Lazaridis, 2019, Cancer Genomics & Proteomics.

Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.

H. Gogas, G. Aravantinos, G. Fountzilas, 2016, Anticancer research.

Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.

G. Fountzilas, K. Markou, A. Nikolaou, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility.

N. Pavlidis, E. Ioachim, G. Pentheroudakis, 2012, Anticancer research.

1450 POSTER Immunohistochemical Profiling of Signalling Pathways in Cancer of Unknown Primary (CUP)

N. Pavlidis, T. Ciuleanu, G. Pentheroudakis, 2011 .

Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy

E. Giannoulatou, K. Papadopoulou, G. Fountzilas, 2020, Cancer Genomics & Proteomics.

Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe

E. Giannoulatou, T. Ciuleanu, A. Psyrri, 2018, International journal of cancer.

Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy

G. Fountzilas, G. Pentheroudakis, V. Karavasilis, 2009, BMC Cancer.

Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

M. Dimopoulos, U. Dafni, H. Gogas, 2012, PloS one.

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial

M. Dimopoulos, U. Dafni, H. Gogas, 2012, Breast Cancer Research and Treatment.

Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial

C. Papadimitriou, G. Fountzilas, G. Pentheroudakis, 2013, PloS one.

Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung Cancer

G. Fountzilas, P. Kosmidis, S. Murray, 2012, Journal of experimental & clinical cancer research : CR.

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies

H. Gogas, G. Fountzilas, G. Pentheroudakis, 2014, BMC Clinical Pathology.

Adjusting Breast Cancer Patient Prognosis with Non-HER2-Gene Patterns on Chromosome 17

H. Gogas, C. Papadimitriou, G. Aravantinos, 2014, PloS one.

[Simultaneous existence of unicameral bone cysts involving the femur and ischium].

J. Kirkos, P. Hytiroglou, M. Bobos, 2009, Acta orthopaedica et traumatologica turcica.

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes

E. Giannoulatou, H. Gogas, G. Lazaridis, 2016, Breast Cancer Research and Treatment.

Dermatoscopy of melanoma according to type, anatomic site and stage

A. Lallas, K. Liopyris, Z. Apalla, 2021, Italian Journal of Dermatology and Venereology.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

M. Dimopoulos, U. Dafni, N. Pavlidis, 2013, BMC Cancer.

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

H. Gogas, R. Wirtz, G. Aravantinos, 2012, Journal of Translational Medicine.

Relapsed and De Novo Metastatic HER2‐positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome

E. Giannoulatou, G. Lazaridis, K. Papadopoulou, 2019, Clinical breast cancer.

How to spot a basosquamous carcinoma: a study on demographics, clinical-dermatoscopic features and histopathological correlations

A. Lallas, D. Rigopoulos, A. Stratigos, 2021, European Journal of Dermatology.

Complete response of locally advanced basosquamous carcinoma to vismodegib in two patients

A. Lallas, Z. Apalla, D. Ioannides, 2019, European Journal of Dermatology.

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study

H. Gogas, R. Wirtz, G. Aravantinos, 2015, Journal of Translational Medicine.

A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas

G. Fountzilas, G. Pentheroudakis, V. Karavasilis, 2013, Journal of Neurology.

Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts

P. Hytiroglou, M. Bobos, V. Papanikolaou, 2016, International journal of surgical pathology.

Dermatoscopic predictors of melanoma arising in small- and medium-sized congenital nevi.

A. Lallas, A. Kyrgidis, K. Liopyris, 2020, Journal of the American Academy of Dermatology.

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study

George Fountzilas, Anastasia G. Eleftheraki, George Pentheroudakis, 2011, Breast Cancer Research and Treatment.

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping

K. Syrigos, E. Giannoulatou, G. Fountzilas, 2018, Medical Oncology.

Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline‐Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials

H. Gogas, G. Aravantinos, G. Fountzilas, 2017, Clinical breast cancer.

Trastuzumab Combined with Pegylated Liposomal Doxorubicin in Patients with Metastatic Breast Cancer

H. Gogas, H. Kalofonos, G. Fountzilas, 2009, Oncology.

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

G. Fountzilas, M. Dimopoulos, G. Fountzilas, 2010, Cancer Chemotherapy and Pharmacology.

Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients

V. Vassiliou, G. Fountzilas, E. Samantas, 2013, BMC Clinical Pathology.

Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)

M. Dimopoulos, N. Pavlidis, H. Gogas, 2013, PloS one.

Characterization of tumor suppressor CYLD expression in clear cell renal cell carcinoma

E. Hatzivassiliou, E. Constantinou, M. Bobos, 2022 .

Ribociclib and palbociclib-induced erythema multiforme: a case report

K. Papazisis, M. Bobos, E. Vrana, 2022, Oxford medical case reports.

Heart and lymphoma: An unusual case of secondary cardiac lymphoma manifested through presyncope and syncope episodes and atrial flutter.

G. Kaiafa, A. Kalogera‐Fountzila, M. Bobos, 2017, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study

G. Aravantinos, C. Petraki, A. Psyrri, 2021, Acta oncologica.

p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab

A. Psyrri, Anastasios Stofas, K. Pavlakis, 2015, Pathology & Oncology Research.

In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer Patients

Taiwo A. Togun, U. Dafni, J. Bordeaux, 2014, PloS one.

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab

S. Tejpar, A. Psyrri, G. Fountzilas, 2014, Journal of Cancer Research and Clinical Oncology.

Evaluation of current prognostic and predictive markers in breast cancer: a validation study of tissue microarrays.

G. Fountzilas, A. Batistatou, A. Eleftheraki, 2013, Anticancer research.

The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.

G. Fountzilas, G. Pentheroudakis, A. Batistatou, 2014, Breast.

Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.

G. Fountzilas, K. Markou, A. Nikolaou, 2012 .

Disease evolution and heterogeneity in bilateral breast cancer.

F. Fostira, E. Giannoulatou, K. Papadopoulou, 2016, American journal of cancer research.